Barbara Fallowfield, Commercial Manager of Mologic was recently interviewed by Anna Macdonald of Technology Networks where they discussed issues clinicians face whilst under pressure to prescribe antibiotics, and how a recent partnership between Fraunhofer UK, and Mologic can help tackle those issues through the development of a novel in vitro diagnostic assay. This assay will provide assistance in accurately treating urinary tract infections, thereby helping to extend the life of current and future antibiotics.
It starts: “Antimicrobial resistance (AMR) is a growing concern to public health, threatening to make surgery, chemotherapy, and treatment to many infections no longer viable.”
Full text of the article can be read at Technology Networks.
Contact us by clicking here.
or E Mail us: